Evaxion Operating Income from 2010 to 2026

EVAX Stock  USD 3.24  0.05  1.52%   
Evaxion Biotech Operating Income yearly trend continues to be fairly stable with very little volatility. Operating Income will likely drop to about -13.9 M in 2026. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Evaxion Biotech AS generates from its operations. View All Fundamentals
 
Operating Income  
First Reported
2019-12-31
Previous Quarter
-4.3 M
Current Value
M
Quarterly Volatility
2.1 M
 
Covid
 
Interest Hikes
Check Evaxion Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evaxion Biotech's main balance sheet or income statement drivers, such as Interest Income of 277.5 K, Depreciation And Amortization of 376.7 K or Interest Expense of 1 M, as well as many indicators such as Price To Sales Ratio of 1.48, Dividend Yield of 0.0 or Days Sales Outstanding of 162. Evaxion financial statements analysis is a perfect complement when working with Evaxion Biotech Valuation or Volatility modules.
  
Build AI portfolio with Evaxion Stock
Check out the analysis of Evaxion Biotech Correlation against competitors.
The evolution of Operating Income for Evaxion Biotech AS provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Evaxion Biotech compares to historical norms and industry peers.

Latest Evaxion Biotech's Operating Income Growth Pattern

Below is the plot of the Operating Income of Evaxion Biotech AS over the last few years. Operating Income is the amount of profit realized from Evaxion Biotech AS operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Evaxion Biotech AS is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Evaxion Biotech's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evaxion Biotech's overall financial position and show how it may be relating to other accounts over time.
Operating Income10 Years Trend
Slightly volatile
   Operating Income   
       Timeline  

Evaxion Operating Income Regression Statistics

Arithmetic Mean(11,398,782)
Coefficient Of Variation(64.49)
Mean Deviation6,115,772
Median(5,627,000)
Standard Deviation7,351,446
Sample Variance54T
Range20.2M
R-Value(0.71)
Mean Square Error28.3T
R-Squared0.51
Significance0
Slope(1,039,327)
Total Sum of Squares864.7T

Evaxion Operating Income History

2026-13.9 M
2025-13.3 M
2024-14.7 M
2023-22.2 M
2022-25.3 M
2021-25.8 M
2020-16.6 M

About Evaxion Biotech Financial Statements

Evaxion Biotech investors use historical fundamental indicators, such as Evaxion Biotech's Operating Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Evaxion Biotech. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Income-13.3 M-13.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Evaxion Stock Analysis

When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.